By Teresa Ooi CSL’s first-half net profit fell 19 per cent to $500 million as unfavourable currency exchange rates wiped $47m from its bottom line and the blood products manufacturer continued to face weak economic conditions in key global markets. Despite the drop in earnings, CSL will pay a dividend of 35c per share unfranked […]